Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Benzinga

Fed's Kugler Sees Inflation Progress But Warns: 'Policy Is Not On A Preset Course'

Federal Reserve Governor Adriana Kugler addresses inflation and labor market concerns, highlighting productivity gains and flexibility in monetary policy.

Benzinga

McDonald's's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on McDonald's (NYSE:MCD).

Benzinga

Tesla Vs. BYD: The EV Duel Heats Up

Tesla dominates premium EV market, while BYD reshapes mid-tier and budget markets with affordability. Despite Tesla's bullish surge, BYD struggles.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Intel's New CEO Change Unlikely To Help Gain Traction Versus Taiwan Semi And Nvidia: Analysts

Intel Corp (NASDAQ: INTC) narrows search for new CEO, ex-board member Lip-Bu Tan a potential candidate. Struggling chipmaker's stock down 52% YTD.

Benzinga

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

The Analyst Verdict: Zscaler In The Eyes Of 23 Experts

Zscaler (NASDAQ:ZS) underwent analysis by 23 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Demystifying Agilysys: Insights From 8 Analyst Reviews

Analysts' ratings for Agilysys (NASDAQ:AGYS) over the last quarter vary from bullish to bearish, as provided by 8 analysts.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Key Takeaways From Maplebear Analyst Ratings

In the last three months, 18 analysts have published ratings on Maplebear (NASDAQ:CART), offering a diverse range of perspectives from bullish to bearish.

Benzinga

Analyst Ratings For Interparfums

In the preceding three months, 8 analysts have released ratings for Interparfums (NASDAQ:IPAR), presenting a wide array of perspectives from bullish to bearish.

Benzinga

The Analyst Landscape: 39 Takes On Walmart

Throughout the last three months, 39 analysts have evaluated Walmart (NYSE:WMT), offering a diverse set of opinions from bullish to bearish.

Benzinga

Nebraska's Two-Front War On Cannabis

Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.

Benzinga

Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments

Pfizer's Chris Boshoff outlines plans to prioritize high-return projects, with a focus on obesity, Oncology, and oral GLP-1 therapies, amid Q3 growth.

Benzinga

US Stocks Pause, South Korea ETFs Fall On Political Turmoil, Oil Prices Rise Above $70: What's Driving Markets Tuesday?

U.S. stocks paused for a breather Tuesday, with major equity indices hovering near the flatline as investors digested global developments, including China’s ban on key raw material exports to the U.S.

Benzinga

Looking At PayPal Holdings's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on PayPal Holdings.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With UNH

Investors with a lot of money to spend have taken a bullish stance on UnitedHealth Group (NYSE:UNH).

Benzinga

Spotlight on Deckers Outdoor: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Deckers Outdoor (NYSE:DECK).

Benzinga

Market Whales and Their Recent Bets on CVNA Options

Investors with a lot of money to spend have taken a bullish stance on Carvana (NYSE:CVNA).

Benzinga

Mastercard's Options: A Look at What the Big Money is Thinking

High-rolling investors have positioned themselves bullish on Mastercard (NYSE:MA), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MA often signals that…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Fragmented Markets To Unified Solutions: How Tokenization Could Reshape Finance

Experts discuss altcoins and tokenization's potential impact on institutional investing. Challenges include liquidity fragmentation and regulatory uncertainty, but optimism remains for a connected future.

Benzinga

Expert Ratings For Thor Industries

In the last three months, 4 analysts have published ratings on Thor Industries (NYSE:THO), offering a diverse range of perspectives from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On BeiGene Through 4 Analysts

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on BeiGene (NASDAQ:BGNE) in the last three months.

Benzinga

Danish Medical Marijuana Producer Stenocare To Launch Patented 10mg THC And 10mg CBD Oil In Norway

A publicly traded Danish medical marijuana operator Stenocare announced Monday the approval of its innovative product, Astrum 10-10, for sale in Norway. This milestone paves the way for more patients to access the benefits of medical cannabis treatment. Astrum 10-10 is expected to become available to patients within the next…

Benzinga

Where Accenture Stands With Analysts

17 analysts have shared their evaluations of Accenture (NYSE:ACN) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Expert Outlook: Sprouts Farmers Market Through The Eyes Of 11 Analysts

Ratings for Sprouts Farmers Market (NASDAQ:SFM) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Unveiling 6 Analyst Insights On US Physical Therapy

During the last three months, 6 analysts shared their evaluations of US Physical Therapy (NYSE:USPH), revealing diverse outlooks from bullish to bearish.

1 … 31 32 33 34

People

Michelle Johnston Holthaus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.